businesspress24.com - Cytori Therapeutics Announces Participation in the 2011 Stem Cell Meeting on the Mesa's Investo
 

Cytori Therapeutics Announces Participation in the 2011 Stem Cell Meeting on the Mesa's Investor and Partnering Forum

ID: 1060578

(firmenpresse) - SAN DIEGO, CA -- (Marketwire) -- 11/28/11 -- Cytori Therapeutics (NASDAQ: CYTX) will present at the 2011 Stem Cell Meeting on the Mesa's Investor and Partnering Forum on December 1. In addition, CEO Christopher Calhoun will participate on a regenerative medicine business panel also on December 1.

Cytori's presentation and panel participation will be video-recorded and posted to the Company's website subsequent to the event.

The following are specific details regarding Cytori's participation at the conference:

Date: December 1, 2011
Time: 11:57 AM PT

Date: December 1, 2011
Time: 3:15 PM PT

The Investor and Partnering Forum will take place at the Sanford Consortium for Regenerative Medicine Building in La Jolla, California. Please see the full conference agenda here: .



The Investor and Partnering Forum is being organized by the Sanford Consortium, CIRM and The Alliance for Regenerative Medicine (ARM) to facilitate translational research, promote engagement between the scientific and business communities and provide opportunities for business, academic research and investor participants to connect in one-on-one strategic partnering meetings. To learn more or to register for the 2011 Stem Cell Meeting on the Mesa Symposium and Investor & Partnering Forum, please visit .



Cytori is a leader in cell therapy, providing patients and physicians around the world with medical technologies that harness the potential of adult regenerative cells from adipose tissue. The Celution® System family of medical devices and instruments is being sold into the European and Asian cosmetic and reconstructive surgery markets but is not yet available in the United States. Our StemSource® product line is sold globally for cell banking and research applications. Our PureGraft® products are available in North America and Europe for fat grafting procedures.



Megan McCormick





+1.858.875.5279


Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  biOasis Announces Non-Brokered Private Placement
Study Showing Potential for microRNAs as Biomarkers for Heart Failure Prognosis Published in European Journal of Heart Failure
Bereitgestellt von Benutzer: MARKET WIRE
Datum: 28.11.2011 - 07:00 Uhr
Sprache: Deutsch
News-ID 1060578
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

SAN DIEGO, CA


Phone:

Kategorie:

Medical Devices


Anmerkungen:


Diese Pressemitteilung wurde bisher 126 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Cytori Therapeutics Announces Participation in the 2011 Stem Cell Meeting on the Mesa's Investor and Partnering Forum
"
steht unter der journalistisch-redaktionellen Verantwortung von

Cytori Therapeutics, Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Cytori Therapeutics, Inc.



 

Who is online

All members: 10 565
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 81


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.